Latest News

Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC

March 28th 2025

Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).

New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time

March 28th 2025

GE HealthCare to Launch PET MPI Agent Flyrcado at ACC Conference
GE HealthCare to Launch PET MPI Agent Flyrcado at ACC Conference

March 28th 2025

Top Five Radiology Content — March 2025
Top Five Radiology Content — March 2025

March 28th 2025

Emerging Research and News in Prostate Cancer Imaging — March 2025
Emerging Research and News in Prostate Cancer Imaging — March 2025

March 27th 2025

Video Interviews

Latest Conference Coverage

View All
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time

March 28th 2025

GE HealthCare to Launch PET MPI Agent Flyrcado at ACC Conference
GE HealthCare to Launch PET MPI Agent Flyrcado at ACC Conference

March 28th 2025

New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI

March 26th 2025

New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA

March 8th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.